S H Kelkar Company Ltd vs Saroja Pharma Industries India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 24, 2026

Key Highlights

The Latest Trading Price of S H Kelkar & Company Ltd is ₹ 119.75 as of 23 Mar 15:30 . The P/E Ratio of S H Kelkar & Company Ltd changed from 10.9 on March 2021 to 33.6 on March 2025 . This represents a CAGR of 25.25% over 5 yearsThe P/E Ratio of Saroja Pharma Industries India Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of S H Kelkar & Company Ltd changed from ₹ 1579 crore on March 2021 to ₹ 2460 crore on March 2025 . This represents a CAGR of 9.27% over 5 yearsThe Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of S H Kelkar & Company Ltd for the Dec '25 is ₹ 617.99 crore as compare to the Sep '25 revenue of ₹ 554.95 crore. This represent the growth of 11.36% The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of S H Kelkar & Company Ltd for the Dec '25 is ₹ 89.53 crore as compare to the Sep '25 ebitda of ₹ 53.45 crore. This represent the growth of 67.5% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of S H Kelkar & Company Ltd changed from ₹ -86.82 crore to ₹ 32.63 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of S H Kelkar & Company Ltd changed from 31.03 % on March 2021 to -102 % on March 2025 . This represents a CAGR of NaN% over 5 yearsThe Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About S H Kelkar & Company Ltd

S H Kelkar & Company Limited was incorporated on July 1, 1955 in Mumbai.
After incorporation, the Company took over businesses carried on by Mr. V.G. Vaze as a sole proprietor of M/s S.H. Kelkar & Co and in partnership by the Firm 'M/s Saraswati Chemical Works'. The Company is engaged into manufacture, supply and exports of fragrances and aroma ingredients used in the food, beverage, personal care or household product industries.
The Company has a diverse and large client base including leading national and multinational FMCG companies, blenders of fragrances & flavours and fragrance & flavour producers. The Company operate 2 business segments, fragrance and flavours segment and also has global ingredients business segment.
The Company's strength is its capability to provide innovative and customised products created by the proficient team of specialised perfumers at the creative development centres in India, Singapore and Europe.

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

FAQs for the comparison of S H Kelkar & Company Ltd and Saroja Pharma Industries India Ltd

Which company has a larger market capitalization, S H Kelkar & Company Ltd or Saroja Pharma Industries India Ltd?

Market cap of S H Kelkar & Company Ltd is 1,657 Cr while Market cap of Saroja Pharma Industries India Ltd is 11 Cr

What are the key factors driving the stock performance of S H Kelkar & Company Ltd and Saroja Pharma Industries India Ltd?

The stock performance of S H Kelkar & Company Ltd and Saroja Pharma Industries India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for S H Kelkar & Company Ltd and Saroja Pharma Industries India Ltd?

As of March 24, 2026, the S H Kelkar & Company Ltd stock price is INR ₹119.75. On the other hand, Saroja Pharma Industries India Ltd stock price is INR ₹28.15.

How do dividend payouts of S H Kelkar & Company Ltd and Saroja Pharma Industries India Ltd compare?

To compare the dividend payouts of S H Kelkar & Company Ltd and Saroja Pharma Industries India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.